TCL Archive New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training June 20, 1986
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012